❯ Google Packs Insulin Resistance Trends Into Pixel Watch 5 and Fitbit

LAUNCHGoogle is adding insulin resistance trend monitoring to its Health Guardian feature suite, debuting with the Pixel Watch 5 and rolling out to the Pixel Watch 3, 4, and Fitbit Air this fall. It’s a step by the consumer-electronics company toward non-invasive glucose monitoring, and blood pressure trend tracking is part of the same rollout.

MECHANICSGoogle’s August 12 note shows Health Guardian doesn’t measure blood glucose directly. The watch collects passive sensor data — resting heart rate, heart rate variability, activity volume, skin temperature changes during sleep, and respiratory rate — and feeds it to an AI model on the Fitbit health platform, which estimates metabolic trends over a rolling one-to-six-week window. When it flags a sustained elevation, it pushes an alert; definitive testing is still left to hospital labs. Apple Watch already collects two of those signals — heart rate and heart rate variability — but stops short of metabolic-level inference. Google’s blood pressure trend feature is in the same batch, and both land this fall on the Fitbit Air and Pixel Watch 3 and later.

LIMITSReading metabolic state from indirect physiological markers is an end-run around the hard problem of non-invasive glucose monitoring. Accuracy and regulatory classification are both unresolved, and Google positions this as a trend alert, not a diagnosis. For the wearables industry, though, the competitive battlefield has shifted from step counting and heart rate to early chronic-disease signals. Whoever first makes these inferences credible to doctors takes the next round of pricing power.

▪ SIGNALGoogle didn’t solve non-invasive glucose monitoring — it just reframed the question so it didn’t need solving.